Doctor profile · Federal record
Dr. Marshall Bedine, M.D.
Gastroenterology Physician (CMS: Gastroenterology) · Specialist · Lutherville, MD
- NPI 1194719658
- 59 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10751 Falls RD, Suite 301
Lutherville, MD 210934517
(410) 583-2633
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- October 22, 2016
- Year of graduation
- 1967 — 59 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State licenses (2)
- Maryland #D07926 · Maryland #D7926
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194719658. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
28,577
Distinct HCPCS
10
Medicare allowed
$757,057
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 20,700 | 19 | $21 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,970 | 17 | $32 | |
J0897 |
Injection, denosumab, 1 mg | 2,280 | 32 | $23 | |
J3489 |
Injection, zoledronic acid, 1 mg | 405 | 81 | $9 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 241 | 143 | $97 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 222 | 209 | $136 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 185 | 62 | $143 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 113 | 100 | $70 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 102 | 102 | $120 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 89 | 29 | $30 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,681. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$2,024
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 33 | $575.99 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $397.19 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $175.25 | |
| Janssen Biotech, Inc. | 9 | $172.36 | |
| PFIZER INC. | 6 | $122.97 | |
| Daiichi Sankyo Inc. | 4 | $102.68 | |
| AIMMUNE THERAPEUTICS, INC. | 2 | $68.32 | |
| Lilly USA, LLC | 2 | $48.44 | |
| Phathom Pharmaceuticals, Inc. | 2 | $45.10 | |
| GENZYME CORPORATION | 1 | $34.74 | |
| QOL Medical, LLC | 1 | $34.60 | |
| Mallinckrodt Hospital Products Inc. | 1 | $31.75 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30.28 | |
| Celgene Corporation | 1 | $26.64 | |
| Madrigal Pharmaceuticals | 1 | $25.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
464
Patients
84
Total drug cost
$108,468
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 69 | 26 | $1,129 |
| Esomeprazole Magnesium | Generic | 62 | 15 | $5,655 |
| Omeprazole | Generic | 48 | 19 | $976 |
| Nortriptyline Hcl | Generic | 35 | 0 | $387 |
| Famotidine | Generic | 30 | 11 | $724 |
| Mesalamine | Generic | 29 | 0 | $37,308 |
| Linzess (Linaclotide) | Brand | 28 | 0 | $25,539 |
| Budesonide Dr (Budesonide) | Brand | 27 | 0 | $16,386 |
| Dicyclomine Hcl | Generic | 26 | 13 | $761 |
| Lansoprazole | Generic | 25 | 0 | $1,274 |
Hospital affiliations
Frequently asked questions
What is Dr. Marshall Bedine's medical specialty?
Dr. Marshall Bedine practices Gastroenterology Physician in Lutherville, MD.
Where does Dr. Marshall Bedine practice?
Dr. Marshall Bedine practices at 10751 Falls RD, Lutherville, MD 210934517. Office phone: 4105832633.
What is Dr. Marshall Bedine's NPI?
Dr. Marshall Bedine's National Provider Identifier (NPI) is 1194719658, issued by NPPES.
Does Dr. Marshall Bedine accept Medicare assignment?
Dr. Marshall Bedine does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Marshall Bedine commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.